Limits...
Cost of lifetime immunosuppression coverage for kidney transplant recipients.

Page TF, Woodward RS - Health Care Financ Rev (2008)

Bottom Line: This research estimates the impact of extending this lifetime coverage to all kidney transplant recipients on Medicare's cash flows.The study finds that extending coverage to all kidney transplant recipients would have increased Medicare's net cash outflows if the coverage were extended for patients of all income levels.There is evidence that extending coverage to only patients in the lowest income quartile could have resulted in a net cost savings to Medicare.

View Article: PubMed Central - PubMed

Affiliation: Florida International University, Miami, FL 33199, USA. tpage@fiu.edu

ABSTRACT
On January 1, 2000, Medicare extended the coverage of immunosuppression medications from 3 years to life for elderly and disabled kidney transplant recipients. This research estimates the impact of extending this lifetime coverage to all kidney transplant recipients on Medicare's cash flows. The study finds that extending coverage to all kidney transplant recipients would have increased Medicare's net cash outflows if the coverage were extended for patients of all income levels. There is evidence that extending coverage to only patients in the lowest income quartile could have resulted in a net cost savings to Medicare.

Show MeSH

Related in: MedlinePlus

Probability of Graft Survival Following Transplantation, by Income Quartile
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4195054&req=5

f1-hcfr-30-02-095: Probability of Graft Survival Following Transplantation, by Income Quartile

Mentions: To determine the differences in graft survival rates between high and low income ineligibles, we constructed Kaplan-Meier survival curves for each ineligible income quartile (Figure 1). These Kaplan-Meier survival curves reflect the probability of graft survival on each day, adjusted for censoring. That is, the probability of graft failure on day t is given by the number of failures on day t divided by the number of patients who are still in the sample on day t. The Kaplan-Meier survival curve represents the residual remaining after the proportion of failures has been subtracted from 100 percent.


Cost of lifetime immunosuppression coverage for kidney transplant recipients.

Page TF, Woodward RS - Health Care Financ Rev (2008)

Probability of Graft Survival Following Transplantation, by Income Quartile
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4195054&req=5

f1-hcfr-30-02-095: Probability of Graft Survival Following Transplantation, by Income Quartile
Mentions: To determine the differences in graft survival rates between high and low income ineligibles, we constructed Kaplan-Meier survival curves for each ineligible income quartile (Figure 1). These Kaplan-Meier survival curves reflect the probability of graft survival on each day, adjusted for censoring. That is, the probability of graft failure on day t is given by the number of failures on day t divided by the number of patients who are still in the sample on day t. The Kaplan-Meier survival curve represents the residual remaining after the proportion of failures has been subtracted from 100 percent.

Bottom Line: This research estimates the impact of extending this lifetime coverage to all kidney transplant recipients on Medicare's cash flows.The study finds that extending coverage to all kidney transplant recipients would have increased Medicare's net cash outflows if the coverage were extended for patients of all income levels.There is evidence that extending coverage to only patients in the lowest income quartile could have resulted in a net cost savings to Medicare.

View Article: PubMed Central - PubMed

Affiliation: Florida International University, Miami, FL 33199, USA. tpage@fiu.edu

ABSTRACT
On January 1, 2000, Medicare extended the coverage of immunosuppression medications from 3 years to life for elderly and disabled kidney transplant recipients. This research estimates the impact of extending this lifetime coverage to all kidney transplant recipients on Medicare's cash flows. The study finds that extending coverage to all kidney transplant recipients would have increased Medicare's net cash outflows if the coverage were extended for patients of all income levels. There is evidence that extending coverage to only patients in the lowest income quartile could have resulted in a net cost savings to Medicare.

Show MeSH
Related in: MedlinePlus